Efficacy of Immunotherapy Plus a Drug in Patients With Progressive Advanced Mucosal Cancer of Different Locations

NCT04357873 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

112

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Lung Cancer
Vulvar Cancer
Penile Cancer
Cervix Cancer
Head and Neck Squamous Cell Carcinoma
Anal Cancer

Interventions

DRUG: pembrolizumab; vorinostat

Sponsor

UNICANCER

Collaborators

[object Object]
[object Object]
[object Object]